On day 6, the GPR43-OE group showed significantly shorter latency to target time than the AD group (50.3 ± 2.550 s vs. 45.69 ± 5.493 s; p < 0.05; Fig. 2B). Here, FFAR2 is linked to Alzheimer disease.